<p>C57BL/6 mice were vaccinated with PBS (n = 4; open symbols), <i>ssaV</i> (5×10<sup>7</sup> cfu; n = 9; grey) or Z234 (5×10<sup>7</sup> cfu; n = 13; black). 40 days post immunization (PBS (n = 4); M2735 (n = 5); Z234 (n = 7)), mice were ampicillin-treated (20 mg by gavage) and challenged with wt SB300 (amp<sup>r</sup>, sm<sup>r</sup>) for two days.. Colonization of cecum (A), MLN (C), Spleen (D) and cecal pathology (B) after wt <i>S</i>. Typhimurium, day 2 post challenge was shown accordingly. Disease parameters (vaccination control data) were determined as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0045433#pone.0045433.s003" target="_blank">Figure S3B</a>. Striped line: detection limit.</p
<p>(A) BALB/c mice (n = 15) were immunized with individual antigens (IsdB, Hla, HI, IH) and alum adj...
<p><b>A</b>. Schematic showing the vaccination protocol. Mice were vaccinated by gene-gun twice at 3...
<p>C3H/HeN mice were immunized with peptides derived from the VWFA domain of BB0172 (A, B, C and D) ...
<p>Vaccinated C57BL/6 mice groups (PBS: n = 4, MT12: n = 4 and MT13: n = 4) were ampicillin-treated ...
<p>Vaccination-challenge experiment to analyze the immunogenic potential of <i>S.</i> Typhimurium M1...
<p>Bacterial loads in the <b>(A)</b> Peyer’s patches (PP), <b>(B)</b> mesenteric lymph nodes (MLN), ...
<p>B6, <i>MyD88<sup>−/−</sup></i> and <i>MyD88<sup>−/−</sup>Gt</i> mice were immunized intravenously...
A-C) Wild-type C57BL/6 mice were given an oral gavage of 5×109cfu S. Typhimurium LAV strain BRD509 (...
<p>(A) Study design: BALB/c mice were vaccinated intranasally with the pressurized H3N8 at the indic...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
<p><b>(A)</b> Scheme of immunotherapy experiments. BALB/c mice were infected with a low dose aerosol...
<p><b>A</b>. Naïve C57BL/6 mice (black) or mice subcutaneously primed with 10<sup>7</sup> empty-vect...
<p>C57BL/6 mice were immunized in the right footpad with <i>L. tarentolae CPA/CPB/EGFP</i> (G1; rLiv...
<p>Groups of ten BALB/c mice (3-week-old) were vaccinated with 5×10<sup>4</sup> PFU MVTT1, MVTT2 or ...
<p>At 90 days post-immunization, mice were challenged with 10<sup>4</sup> PFUs of FMDV C-S8c1 (proce...
<p>(A) BALB/c mice (n = 15) were immunized with individual antigens (IsdB, Hla, HI, IH) and alum adj...
<p><b>A</b>. Schematic showing the vaccination protocol. Mice were vaccinated by gene-gun twice at 3...
<p>C3H/HeN mice were immunized with peptides derived from the VWFA domain of BB0172 (A, B, C and D) ...
<p>Vaccinated C57BL/6 mice groups (PBS: n = 4, MT12: n = 4 and MT13: n = 4) were ampicillin-treated ...
<p>Vaccination-challenge experiment to analyze the immunogenic potential of <i>S.</i> Typhimurium M1...
<p>Bacterial loads in the <b>(A)</b> Peyer’s patches (PP), <b>(B)</b> mesenteric lymph nodes (MLN), ...
<p>B6, <i>MyD88<sup>−/−</sup></i> and <i>MyD88<sup>−/−</sup>Gt</i> mice were immunized intravenously...
A-C) Wild-type C57BL/6 mice were given an oral gavage of 5×109cfu S. Typhimurium LAV strain BRD509 (...
<p>(A) Study design: BALB/c mice were vaccinated intranasally with the pressurized H3N8 at the indic...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
<p><b>(A)</b> Scheme of immunotherapy experiments. BALB/c mice were infected with a low dose aerosol...
<p><b>A</b>. Naïve C57BL/6 mice (black) or mice subcutaneously primed with 10<sup>7</sup> empty-vect...
<p>C57BL/6 mice were immunized in the right footpad with <i>L. tarentolae CPA/CPB/EGFP</i> (G1; rLiv...
<p>Groups of ten BALB/c mice (3-week-old) were vaccinated with 5×10<sup>4</sup> PFU MVTT1, MVTT2 or ...
<p>At 90 days post-immunization, mice were challenged with 10<sup>4</sup> PFUs of FMDV C-S8c1 (proce...
<p>(A) BALB/c mice (n = 15) were immunized with individual antigens (IsdB, Hla, HI, IH) and alum adj...
<p><b>A</b>. Schematic showing the vaccination protocol. Mice were vaccinated by gene-gun twice at 3...
<p>C3H/HeN mice were immunized with peptides derived from the VWFA domain of BB0172 (A, B, C and D) ...